Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: McNeil's Imodium Advanced

This article was originally published in The Tan Sheet

Executive Summary

McNeil's Imodium Advanced: Antidiarrheal granted Waxman/Hatch marketing exclusivity through June 26, 2000; however, the patent, expiring July 28, 2010, will protect the product until the later date. Supporting McNeil Consumer Products' launch of the product (shipped Oct. 16), 15- and 30-second TV spots began running Nov. 10 during the Jay Leno Show. The ads, which will appear through the first quarter of 1998, show a space shuttle delayed by an astronaut who needs quick diarrhea relief. Ammuranti Puris Lintas, New York City, created the ads. FDA approved the NDA for Imodium Advanced (loperamide/simethicone) June 26 ("The Tan Sheet" June 30, p. 2)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087777

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel